Ace Therapeutics is committed to supporting customers to drive scientific innovation and develop novel therapeutics.
At Ace Therapeutics, our team of experts is dedicated to advancing the field of gastrointestinal (GI) and liver disease research. With a profound understanding of these complex disease areas, we provide exceptional preclinical research services and comprehensive drug development support.
GRED, Gastric ulcer, gastritis, appendicitis, Crohn disease, IBD, IBS
NALDs, ALDs, hepatitis, fatty liver, liver Fibrosis, liver failure
Pancreatitis, pancreatic microcirculation disorder
Cholecystitis, cholangitis, biliary atresia, gallstone
Ace Therapeutics is at the forefront of gastrointestinal and hepatic disease research, offering a cutting-edge technology platform for preclinical studies and drug development. Our platform integrates advanced methodologies and state-of-the-art technologies to provide comprehensive solutions.